iRay Group (SHA:688301)
119.79
+4.29 (3.71%)
At close: Jan 23, 2026
iRay Group Market Cap
iRay Group has a market cap or net worth of 25.3 billion as of January 23, 2026. Its market cap has increased by 86.56% in one year.
Market Cap
25.30B
Enterprise Value
25.69B
Revenue
2.02B
Ranking
n/a
PE Ratio
45.59
Stock Price
119.79
Market Cap Chart
Since September 18, 2020, iRay Group's market cap has increased from 11.61B to 25.30B, an increase of 117.83%. That is a compound annual growth rate of 15.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 25.30B | 18.45% |
| Dec 31, 2025 | 21.36B | 56.41% |
| Dec 31, 2024 | 13.66B | -58.82% |
| Dec 29, 2023 | 33.16B | -0.38% |
| Dec 30, 2022 | 33.28B | -7.67% |
| Dec 31, 2021 | 36.05B | 189.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Imeik Technology Development | 42.68B |
| Gan & Lee Pharmaceuticals. | 41.96B |
| Intco Medical Technology | 28.10B |
| Winner Medical | 21.51B |
| Zhende Medical | 18.85B |
| Shenyang Xingqi Pharmaceutical | 18.37B |
| Andon Health | 17.79B |
| Micro-Tech (Nanjing) Co.,Ltd | 15.98B |